| (S)-nicotine | increases expression | ISO | RGD:1307891 | 6480464 | Nicotine results in increased expression of ADIPOR2 mRNA | CTD | PMID:22265867 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1317350 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADIPOR2 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ADIPOR2 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of ADIPOR2 mRNA | CTD | PMID:19619570 PMID:21185374 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of ADIPOR2 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of ADIPOR2 mRNA | CTD | PMID:17404688 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ADIPOR2 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1317350 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ADIPOR2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317350 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ADIPOR2 mRNA | CTD | PMID:20159946 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1317350 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ADIPOR2 mRNA | CTD | PMID:16214954 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ADIPOR2 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1317350 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADIPOR2 mRNA | CTD | PMID:17942748 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:1307891 | 6480464 | 2,4-dinitrotoluene affects the expression of ADIPOR2 mRNA | CTD | PMID:21346803 |
| 2-methoxyethanol | increases expression | ISO | RGD:1307891 | 6480464 | methyl cellosolve results in increased expression of ADIPOR2 mRNA | CTD | PMID:21061450 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | RGD:1307891 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ADIPOR2 mRNA | CTD | PMID:20959002 |
| acetaldehyde | multiple interactions | ISO | RGD:1317350 | 6480464 | Acetaldehyde inhibits the reaction [LEP protein results in increased expression of ADIPOR2 protein] | CTD | PMID:17949463 |
| acetaldehyde | increases expression | ISO | RGD:1317350 | 6480464 | Acetaldehyde results in increased expression of ADIPOR2 protein | CTD | PMID:17949463 |
| allopurinol | multiple interactions | ISO | RGD:1307891 | 6480464 | Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOR2 protein]] | CTD | PMID:21912612 |
| benzo[a]pyrene | increases expression | ISO | RGD:1317350 | 6480464 | Benzo(a)pyrene results in increased expression of ADIPOR2 mRNA | CTD | PMID:21964900 |
| bezafibrate | increases expression | ISO | RGD:1317350 | 6480464 | Bezafibrate results in increased expression of ADIPOR2 mRNA | CTD | PMID:16574099 |
| caffeine | increases expression | ISO | RGD:1307891 | 6480464 | Caffeine results in increased expression of ADIPOR2 mRNA | CTD | PMID:22583948 |
| choline | multiple interactions | ISO | RGD:1317350 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ADIPOR2 mRNA | CTD | PMID:20938992 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of ADIPOR2 mRNA | CTD | PMID:19549813 |
| D-glucose | decreases expression | ISO | RGD:1307891 | 6480464 | Glucose results in decreased expression of ADIPOR2 protein | CTD | PMID:21912612 |
| D-glucose | multiple interactions | ISO | RGD:1307891 | 6480464 | ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] | CTD | PMID:21912612 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone promotes the reaction [rosiglitazone results in increased activity of ADIPOR2 promoter] | CTD | PMID:16609881 |
| dibutyl phthalate | decreases expression | ISO | RGD:1307891 | 6480464 | Dibutyl Phthalate results in decreased expression of ADIPOR2 mRNA | CTD | PMID:21266533 |
| ethanol | multiple interactions | ISO | RGD:1317350 | 6480464 | [rosiglitazone co-treated with Ethanol] results in increased expression of ADIPOR2 mRNA | CTD | PMID:20007851 |
| ethanol | decreases expression | ISO | RGD:1317350 | 6480464 | Ethanol results in decreased expression of ADIPOR2 mRNA | CTD | PMID:18755807 PMID:20007851 |
| ethanol | decreases expression | ISO | RGD:1317350 | 6480464 | Ethanol results in decreased expression of ADIPOR2 mRNA | CTD | PMID:20007851 |
| fenofibrate | increases expression | ISO | RGD:1317350 | 6480464 | Fenofibrate results in increased expression of ADIPOR2 mRNA | CTD | PMID:16306350 |
| folic acid | multiple interactions | ISO | RGD:1317350 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ADIPOR2 mRNA | CTD | PMID:20938992 |
| glucose | decreases expression | ISO | RGD:1307891 | 6480464 | Glucose results in decreased expression of ADIPOR2 protein | CTD | PMID:21912612 |
| glucose | multiple interactions | ISO | RGD:1307891 | 6480464 | ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] | CTD | PMID:21912612 |
| gold atom | multiple interactions | ISO | RGD:1317350 | 6480464 | [Gold co-treated with Polyethylene Glycols] results in decreased expression of ADIPOR2 mRNA | CTD | PMID:19695318 |
| gold(0) | multiple interactions | ISO | RGD:1317350 | 6480464 | [Gold co-treated with Polyethylene Glycols] results in decreased expression of ADIPOR2 mRNA | CTD | PMID:19695318 |
| L-methionine | multiple interactions | ISO | RGD:1317350 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ADIPOR2 mRNA | CTD | PMID:20938992 |
| lead diacetate | increases expression | ISO | RGD:1317350 | 6480464 | lead acetate results in increased expression of ADIPOR2 mRNA | CTD | PMID:21829687 |
| methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of ADIPOR2 mRNA | CTD | PMID:17400583 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [rosiglitazone results in increased activity of ADIPOR2 promoter] | CTD | PMID:16609881 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1307891 | 6480464 | Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOR2 protein]; more ... | CTD | PMID:21912612 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:1307891 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ADIPOR2 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | increases expression | ISO | RGD:1317350 | 6480464 | perfluorooctanoic acid results in increased expression of ADIPOR2 mRNA | CTD | PMID:17681415 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:1307891 | 6480464 | perfluorooctanoic acid results in decreased expression of ADIPOR2 mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | ISO | RGD:1317350 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ADIPOR2 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:1317350 | 6480464 | pirinixic acid results in increased expression of ADIPOR2 mRNA | CTD | PMID:16306350 PMID:18301758 |
| pirinixic acid | increases expression | ISO | RGD:1317350 | 6480464 | pirinixic acid results in increased expression of ADIPOR2 mRNA | CTD | PMID:18301758 PMID:16306350 |
| pirinixic acid | increases expression | ISO | RGD:1307891 | 6480464 | pirinixic acid results in increased expression of ADIPOR2 mRNA | CTD | PMID:19162173 |
| piroxicam | decreases expression | EXP | | 6480464 | Piroxicam results in decreased expression of ADIPOR2 mRNA | CTD | PMID:21858171 |
| progesterone | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of ADIPOR2 mRNA | CTD | PMID:17404688 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of ADIPOR2 mRNA | CTD | PMID:17404688 |
| propiconazole | decreases expression | ISO | RGD:1317350 | 6480464 | propiconazole results in decreased expression of ADIPOR2 mRNA | CTD | PMID:21278054 |
| resveratrol | increases expression | ISO | RGD:1317350 | 6480464 | resveratrol results in increased expression of ADIPOR2 mRNA | CTD | PMID:18755807 |
| rosiglitazone | increases expression | ISO | RGD:1317350 | 6480464 | rosiglitazone results in increased expression of ADIPOR2 mRNA | CTD | PMID:16306350 |
| rosiglitazone | increases expression | ISO | RGD:1317350 | 6480464 | rosiglitazone results in increased expression of ADIPOR2 mRNA | CTD | PMID:16306350 PMID:16609881 |
| rosiglitazone | multiple interactions | ISO | RGD:1317350 | 6480464 | rosiglitazone inhibits the reaction [Linoleic Acids, Conjugated results in decreased expression of ADIPOR2 mRNA] | CTD | PMID:17322064 |
| rosiglitazone | multiple interactions | ISO | RGD:1307891 | 6480464 | rosiglitazone affects the reaction [Dietary Fats affects the expression of ADIPOR2 mRNA]; more ... | CTD | PMID:20965162 |
| rosiglitazone | increases expression | ISO | RGD:1317350 | 6480464 | rosiglitazone results in increased expression of ADIPOR2 mRNA | CTD | PMID:16609881 PMID:16306350 |
| rosiglitazone | multiple interactions | ISO | RGD:1317350 | 6480464 | [rosiglitazone co-treated with Ethanol] results in increased expression of ADIPOR2 mRNA | CTD | PMID:20007851 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of ADIPOR2 mRNA; more ... | CTD | PMID:16609881 |
| rosiglitazone | increases activity | EXP | | 6480464 | rosiglitazone results in increased activity of ADIPOR2 promoter | CTD | PMID:16609881 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | Dexamethasone promotes the reaction [rosiglitazone results in increased activity of ADIPOR2 promoter]; more ... | CTD | PMID:16609881 |
| streptozocin | multiple interactions | ISO | RGD:1307891 | 6480464 | Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOR2 protein]; more ... | CTD | PMID:21912612 |
| streptozocin | decreases expression | ISO | RGD:1307891 | 6480464 | Streptozocin results in decreased expression of ADIPOR2 protein | CTD | PMID:21912612 |
| sulindac | multiple interactions | ISO | RGD:1307891 | 6480464 | [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ADIPOR2 mRNA | CTD | PMID:20371263 |
| tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of ADIPOR2 mRNA | CTD | PMID:15336504 |
| tetracycline | increases expression | ISO | RGD:1317350 | 6480464 | Tetracycline results in increased expression of ADIPOR2 mRNA | CTD | PMID:16917069 |
| trans-resveratrol | increases expression | ISO | RGD:1317350 | 6480464 | resveratrol results in increased expression of ADIPOR2 mRNA | CTD | PMID:18755807 |
| zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ADIPOR2 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ADIPOR2 mRNA | CTD | PMID:18593933 |